Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant.
Am J Transplant. 2019 Jan;19(1):98-109. doi: 10.1111/ajt.15011. Epub 2018 Aug 31.
Am J Transplant. 2019.
PMID: 29985559
Free PMC article.
Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients.
Park S, Guo K, Heilman RL, Poggio ED, Taber DJ, Marsh CL, Kurian SM, Kleiboeker S, Weems J, Holman J, Zhao L, Sinha R, Brietigam S, Rebello C, Abecassis MM, Friedewald JJ.
Park S, et al.
Clin J Am Soc Nephrol. 2021 Oct;16(10):1539-1551. doi: 10.2215/CJN.05530421.
Clin J Am Soc Nephrol. 2021.
PMID: 34620649
Free PMC article.
Item in Clipboard
Orthogonal Comparison of Molecular Signatures of Kidney Transplants With Subclinical and Clinical Acute Rejection: Equivalent Performance Is Agnostic to Both Technology and Platform.
Kurian SM, Velazquez E, Thompson R, Whisenant T, Rose S, Riley N, Harrison F, Gelbart T, Friedewald JJ, Charette J, Brietigam S, Peysakhovich J, First MR, Abecassis MM, Salomon DR.
Kurian SM, et al.
Am J Transplant. 2017 Aug;17(8):2103-2116. doi: 10.1111/ajt.14224. Epub 2017 Apr 3.
Am J Transplant. 2017.
PMID: 28188669
Free PMC article.
Item in Clipboard
Cite
Cite